According to a market report by Lucintel, the future of the global PD-L1 biomarker testing market looks promising with opportunities in the hospital and diagnostic center markets. The global PD-L1 biomarker testing market is expected to grow with a CAGR of 12.5% from 2025 to 2031. The major drivers for this market are the increasing adoption of personalized cancer treatments, the rising demand for targeted therapies, and the growing awareness of cancer biomarker testing.A more than 150-page report to understand trends, opportunity and forecast in PD-L1 biomarker testing market to 2031 by type (PD-L1 (22C3), PD-L1(28-8), PD-L1 (SP142), PD-L1 (SP263), and others), application (hospital, diagnostic center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, PD-L1 (22C3) is expected to witness the highest growth over the forecast period.
Within the application category, diagnostic center is expected to witness higher growth.
Download sample by clicking on PD-L1 biomarker testing market
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Agilent Technologies, Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences are the major suppliers in the PD-L1 biomarker testing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
SMT Placement Equipment Market
Single-use Bioprocessing Market
Single Cell Sequencing Market
SiC Polishing Consumable Market
Sensory-Friendly Therapeutic Tool Market